This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
New Paradigms in Cancer Therapeutics
joint with Integration of Developmental Signaling Pathways
Organizer(s): Arul M. Chinnaiyan and William R. Sellers
Date: March 23 - 28, 2010
Location: Fairmont Empress Victoria / Victoria Conference Centre, Victoria, BC, Canada
Sponsored by Abbott Laboratories, Genentech BioOncology and sanofi-aventis
Summary of Meeting:
The advent of genome-scale profiling technologies has opened up the possibility of comprehensively monitoring multiple layers of molecular aberrations in cancer. Alterations in the epigenome, genome, transcriptome, proteome and metabolome have all been observed in tumor development. A number of key molecular pathways have been found to be altered during cancer progression. Pivotal questions in the field include: Can these novel pathways alone or in combination be effectively targeted in cancer? Can we identify molecular signatures that will facilitate personalized medicine? What are the innovative therapeutic modalities that can be employed to target these pathways? The goal of this meeting is to tackle promising new targets for cancer therapy. These include targets such as recurrent gene fusions, epigenetic pathways, and metabolic networks. We will also explore the use of molecular marker panels to select patients for treatment. A number of approaches to therapeutic targeting will be discussed including novel biologics and RNA interference.
Scholarship Deadline: November 24 2009
Discounted Abstract Deadline: November 24 2009
Abstract Deadline: December 29 2009
Discounted Registration Deadline: January 25 2010
We gratefully acknowledge additional support for this conference from:
Abbott LaboratoriesCell Signaling Technology, Inc.Exelixis, Inc.Genentech BioOncologySanofi US
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Micromet, Inc.

Novartis Institutes for BioMedical Research

Tekmira
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
ACS Publications
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13CA144367-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found